ArticleTheranostics2023

Developing an efficient MGCR microneedle nanovaccine patch for eliciting Th 1 cellular response against the SARS-CoV-2 infection.

Ang Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.